Proteinase administration reduces growth of human breast and pancreatic cancer in nude mice and diminishes expression of some tumorigenesis biomarkers

International Journal of Immunotherapy

Volumn 17, Issue 2-4, 2001, Pages 65-73

  Wald, M ^a   Sebkova V ^a   Osterreicher J ^a   Zadinova M ^a   Pouckova P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL ADHESION MOLECULE; CYSTEINE PROTEINASE; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN BCL 2; SERINE PROTEINASE; SODIUM CHLORIDE; TUMOR MARKER; WOBE MUGOS E;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL SURFACE; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME THERAPY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE C ERB; PANCREAS CANCER; PROTEIN EXPRESSION; TISSUE NECROSIS; TUMOR CELL; TUMOR GROWTH;

EID: 0035724017     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 6 mice with syngeneic melanoma B16
2. Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice
3. Proteinases reduce metastatic dissemination and increase survival time in C57Bl6 mice with Lewis' lung carcinoma
4. Potential of targeting cell surface CD44 proteins with proteinases in preventing tumor growth and metastasis
5. Chemoprevention of cancer for the next millennium - Quo vadis?
6. The effect of proteinases on survival and certain haematological parameters in SD/lpcv rats with spontaneous lymphoblastic leukaemia
7. Antimetastatic effect of bromelain with or without its proteolytic and anticoagulant activity
8. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice
9. Comparison between different cell kinetic variables in human breast cancer
10. p53 protein expression and proliferative activity in ductal breast carcinomas
11. The prognostic value of proliferation indices: A study with in vivo bromodeoxyuridine and Ki-67
12. ERBB-2 overexpression confers PI 3′ kinase-dependent invasion capacity on human mammary epithelial cells
13. Immunohistochemical analysis of overexpression of c-erbB-2 protein in node-positive breast carcinoma
14. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer
15. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
16. HER-2/neu amplification predicts poor survival in node-positive breast cancer
17. Follow-up study of HER-2/neu amplification in primary breast cancer
18. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
19. Bromelain proteases modulate the CD44 expression on human molt 4/8 leukaemia and SK-Mel 28 melanoma cells in vitro
20. 2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa
21. "Hematology and Blood Transfusion I"
22. Inhibition of tumour growth in vitro by bromelain, an extract of the pineapple plant (Ananas comosus)
23. Modulation of pulmonary metastasis (Lewis lung carcinoma) by bromelain, an extract of the pineapple stem
24. Effects of oral bromelain administration on the impaired immunotoxicity of mononuclear cells from mammary tumor patients
25. Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2 and p53
26. Breast cancer in the 21st century: Neu opportunities and neu challenges
27. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma
28. Immunomodulation by proteolytic enzymes
29. Proteolytic enzymes modulate the adhesion molecule CD44 on malignant cells in vitro
30. Bromelain proteases suppress growth, invasion and lung metastasis of B16F10 mouse melanoma cells